While news media trumpet the arrival of two effective vaccines to guard against COVID-19, there is another story that tempers the excitement.  That is how to distribute them when there is a need to keep an ultra-cold environment.  Both Pfizer and Moderna are working quickly on solutions for transporting the medicines but they are far from a complete solution.  The problem is there are not enough refrigerated trucks and other conveyances to keep the vaccine from thawing and losing potency.  So while the two companies benefitted from publicity about the vaccines’ effectiveness, their emerging success overshadows the real challenge of logistics.  The two companies could be breeding a PR nightmare for themselves as they roll out millions of doses only to find they can’t efficiently distribute them.  One hopes PR executives in the two companies are cautioning their bosses about stoking excitement over initial success.  There is still a long way to go.

Post Your Resume to 65+ Job Sites
Resume Service

Post to Twitter Tweet This Post